Walgreens Boots Alliance Inc (W8A.BE)
| Previous close | 16.56 |
| Open | 16.37 |
| Bid | 16.37 x 0 |
| Ask | 16.50 x 0 |
| Day's range | 16.37 - 16.37 |
| 52-week range | 16.35 - 31.80 |
| Volume | |
| Avg. volume | 10 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 25 June 2024 - 01 July 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Yahoo FinanceWalgreens launches specialty pharmacy unit to compete in new PBM era
Walgreens is launching new services and consolidating specialty services to compete in the pharmacy benefits management (PBM) space.
- Business Wire
Walgreens Boots Alliance Declares Quarterly Dividend
DEERFIELD, Ill., April 25, 2024--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, unchanged from the previous quarter. The dividend is payable on June 12, 2024, to stockholders of record as of May 21, 2024.
BloombergWalgreens Is Opening a New Pharmacy For Cell and Gene Therapies
(Bloomberg) -- Walgreens Boots Alliance Inc. is opening a new center dedicated to bringing emerging cell and gene therapies to patients with complex, chronic conditions like cancer, cystic fibrosis and Crohn’s disease.Most Read from BloombergMalaysia in Talks With Tycoons on Casino to Revive $100 Billion Forest CityBiden’s Gains Against Trump Vanish on Deep Economic Pessimism, Poll ShowsZuckerberg Asks for Patience as Meta’s AI Push Spooks InvestorsMeta’s Miss Sparks Fears in Tech With More Earn
